Skip to main content

Compare Stocks

Date Range: 

 Hybrid EnergyQMedAmerican CaresourcePacific Health Care OrganizationBioRestorative Therapies
SymbolOTCMKTS:HYBEOTCMKTS:QMEDOTCMKTS:GNOWOTCMKTS:PFHOOTCMKTS:BRTX
Price Information
Current Price$0.00$0.00$0.01$1.10$0.01
52 Week RangeN/AN/AN/AN/AN/A
MarketRank™
Overall Score0.00.20.70.80.6
Analysis Score0.00.00.00.00.0
Community Score0.00.02.82.52.9
Dividend Score0.00.00.00.00.0
Ownership Score0.00.80.81.70.0
Earnings & Valuation Score0.00.00.00.00.0
Analyst Ratings
Consensus RecommendationN/AN/AN/AN/AN/A
Consensus Price TargetN/AN/AN/AN/AN/A
% Upside from Price TargetN/AN/AN/AN/AN/A
Trade Information
Market CapN/AN/A$181,000.00$14.08 million$24.93 million
Beta6.783.682.560.589.53
Average Volume14,788,50757,54356,1933,38840,847,809
Sales & Book Value
Annual RevenueN/AN/AN/A$7.33 million$110,000.00
Price / SalesN/AN/AN/A1.92226.65
CashflowN/AN/AN/A$0.10 per shareN/A
Price / CashN/AN/AN/A10.85N/A
Book ValueN/AN/AN/A$0.73 per shareN/A
Price / BookN/AN/AN/A1.51
Profitability
Net IncomeN/AN/AN/A$1.20 million$-12,520,000.00
EPSN/AN/AN/AN/AN/A
Trailing P/E Ratio0.000.000.000.000.00
Forward P/E Ratio
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/AN/A10.25%N/A
Return on Equity (ROE)N/AN/AN/A6.86%N/A
Return on Assets (ROA)N/AN/AN/A6.12%N/A
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/AN/AN/AN/AN/A
Current RatioN/AN/AN/A10.59%N/A
Quick RatioN/AN/AN/A10.59%N/A
Ownership Information
Institutional Ownership PercentageN/AN/AN/AN/AN/A
Insider Ownership Percentage6.03%35.20%51.46%61.60%12.20%
Miscellaneous
EmployeesN/A28111346
Shares OutstandingN/AN/A16.60 million12.80 million3.18 billion
Next Earnings DateN/AN/AN/A5/28/2021 (Estimated)N/A
OptionableNot OptionableNot OptionableNot OptionableNot OptionableNot Optionable
SourceHeadline
BioRestorative Therapies Expanding its Cell Therapy Manufacturing FacilityBioRestorative Therapies Expanding its Cell Therapy Manufacturing Facility
finance.yahoo.com - May 10 at 7:42 AM
BioRestorative Therapies Announces Compliance with SEC Reporting Requirements and “Stop Sign” RemovalBioRestorative Therapies Announces Compliance with SEC Reporting Requirements and “Stop Sign” Removal
finance.yahoo.com - May 3 at 10:00 AM
BioRestorative Therapies Inc (BRTX)BioRestorative Therapies Inc (BRTX)
investing.com - April 29 at 2:14 PM
Short Interest in BioRestorative Therapies, Inc. (OTCMKTS:BRTX) Drops By 79.5%Short Interest in BioRestorative Therapies, Inc. (OTCMKTS:BRTX) Drops By 79.5%
americanbankingnews.com - April 28 at 7:20 AM
BioRestorative Therapies Announces Appointment of Nickolay V. Kukekov, Ph.D to its Board of ...BioRestorative Therapies Announces Appointment of Nickolay V. Kukekov, Ph.D to its Board of ...
apnews.com - April 5 at 7:41 AM
BioRestorative Therapies Announces Appointment of Nickolay V. Kukekov, Ph.D to its Board of DirectorsBioRestorative Therapies Announces Appointment of Nickolay V. Kukekov, Ph.D to its Board of Directors
finance.yahoo.com - April 5 at 7:41 AM
BioRestorative Therapies Announces Notice of Allowance for a New Patent Application Related to ...BioRestorative Therapies Announces Notice of Allowance for a New Patent Application Related to ...
apnews.com - March 31 at 9:04 AM
BioRestorative Therapies Announces Notice of Allowance for a New Patent Application Related to its Off-the-Shelf ThermoStem® ProgramBioRestorative Therapies Announces Notice of Allowance for a New Patent Application Related to its Off-the-Shelf ThermoStem® Program
finance.yahoo.com - March 31 at 9:04 AM
BioRestorative Therapies Announces Notices of Allowance for Three Patent Applications for its ...BioRestorative Therapies Announces Notices of Allowance for Three Patent Applications for its ...
apnews.com - March 22 at 6:58 AM
BioRestorative Therapies Announces Notices of Allowance for Three Patent Applications for its Off-the-Shelf ThermoStem® ProgramBioRestorative Therapies Announces Notices of Allowance for Three Patent Applications for its Off-the-Shelf ThermoStem® Program
finance.yahoo.com - March 22 at 6:58 AM
BioRestorative Therapies Announces Filing of 2019 Annual Report on Form 10-KBioRestorative Therapies Announces Filing of 2019 Annual Report on Form 10-K
finance.yahoo.com - March 19 at 8:34 AM
News for BioRestorative Therapies IncNews for BioRestorative Therapies Inc
markets.businessinsider.com - December 14 at 9:33 PM
BRTX Stock Price Increased 30% Today: Why It HappenedBRTX Stock Price Increased 30% Today: Why It Happened
pulse2.com - December 11 at 5:11 PM
BioRestorative Therapies Emerges from Chapter 11 ReorganizationBioRestorative Therapies Emerges from Chapter 11 Reorganization
finance.yahoo.com - November 20 at 8:20 AM
BioRestorative Therapies Announces Metabolic Research Collaboration with University of PennsylvaniaBioRestorative Therapies Announces Metabolic Research Collaboration with University of Pennsylvania
www.bloomberg.com - July 26 at 11:33 PM
Adipose Derived Stem Cell Therapy Market In-depth Analysis, Expert Reviews and Healthcare Outlook 2020 to 2026Adipose Derived Stem Cell Therapy Market In-depth Analysis, Expert Reviews and Healthcare Outlook 2020 to 2026
www.openpr.com - June 22 at 12:54 PM
BioRestorative Therapies Inc.BioRestorative Therapies Inc.
www.marketwatch.com - April 25 at 10:21 PM
Europe Degenerative Disc Disease Threpeutics Market is slated to grow rapidly in the coming yearsEurope Degenerative Disc Disease Threpeutics Market is slated to grow rapidly in the coming years
www.cmo.com.au - April 2 at 6:47 AM
It’s a Hot Market for SinglesIt’s a Hot Market for Singles
www.wallstreetdaily.com - January 29 at 7:06 PM
BioRestorative Therapies Featured in IEEE Pulse Magazine’s Cover Story About Stem Cell Therapies for Low Back PainBioRestorative Therapies Featured in IEEE Pulse Magazine’s Cover Story About Stem Cell Therapies for Low Back Pain
finance.yahoo.com - December 16 at 12:30 PM
BioRestorative Therapies Receives Patent in Israel For Its Metabolic ProgramBioRestorative Therapies Receives Patent in Israel For Its Metabolic Program
finance.yahoo.com - December 12 at 1:54 PM
BioRestorative Therapies Receives A Second Patent in Australia For Its Metabolic ProgramBioRestorative Therapies Receives A Second Patent in Australia For Its Metabolic Program
finance.yahoo.com - October 23 at 12:18 PM
Biorestorative Therapies IncBiorestorative Therapies Inc
markets.ft.com - October 10 at 11:55 PM
BioRestorative Therapies Scientific Advisory Board Member and Clinical Director of Regenerative Disc/Spine Program, Dr. Wayne J. Olan, to Receive Prestigious AwardBioRestorative Therapies Scientific Advisory Board Member and Clinical Director of Regenerative Disc/Spine Program, Dr. Wayne J. Olan, to Receive Prestigious Award
finance.yahoo.com - September 18 at 12:11 PM
BioRestorative Therapies Comments on Recent Promotional ActivityBioRestorative Therapies Comments on Recent Promotional Activity
finance.yahoo.com - September 13 at 10:18 PM
DateCompanyBrokerageAction
(Data available from 5/18/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.